Appl Environ Microbiol 1997, 63:2047–2053.PubMedCentralPubMed

38. Johnson PE, Deromedi AJ, Lebaron P, Catala P, Cash J: Fountain flow cytometry, a new technique for the rapid detection and enumeration of microorganisms in aqueous samples. Cytometry A 2006, 69:1212–1221.PubMedCrossRef 39. Parthuisot N, Catala P, Lemarchand K, Baudart J, Lebaron P: Evaluation of ChemChrome V6 for bacterial viability assessment in waters. J Appl Microbiol 2000, 89:370–380.PubMedCrossRef 40. Steinert M, Ockert G, Lück C, Hacker J: Regrowth of legionella pneumophila in a heat-disinfected plumbing system. Zentralbl Bakteriol 1998, 288:331–342.PubMedCrossRef 41. Elowitz MB, Levine AJ, Siggia ED, Swain PS: Stochastic gene expression in a single cell. Science 2002, 297:1183–1186.PubMedCrossRef Venetoclax molecular weight 42. Nyström T: A bacterial kind of aging. PLoS Genet 2007, 3:e224.PubMedCentralPubMedCrossRef 43. Hughes V, Jiang C, Brun Y: Caulobacter crescentus. Dabrafenib molecular weight Curr Biol 2012,

22:R507–509.PubMedCrossRef 44. Dubnau D, Losick R: Bistability in bacteria. Mol Microbiol 2006, 61:564–572.PubMedCrossRef 45. Kim SH, Schneider BL, Reitzer L: Genetics and regulation of the major enzymes of alanine synthesis in Escherichia coli. J Bacteriol 2010, 192:5304–5311.PubMedCentralPubMedCrossRef 46. Pine L, Hoffman PS, Malcolm GB, Benson RF, Franzus MJ: Role of keto acids and reduced-oxygen-scavenging enzymes in the growth of legionella species. J Clin Microbiol 1986, 23:33–42.PubMedCentralPubMed 47. Ducret A, Maisonneuve E, Notareschi P, Grossi A, Mignot T, Dukan S: A microscope automated fluidic system to study bacterial processes in real time. PLoS ONE 2009, 4:e7282.PubMedCentralPubMedCrossRef 48. La Scola B, Mezi L, Weiller PJ, Raoult D: Isolation of legionella anisa using an amoebic coculture procedure. J Clin Microbiol 2001, 39:365–366.PubMedCentralPubMedCrossRef

Authors’ Abiraterone contribution Conceived and designed the experiments: AD, SD. Performed the experiments: AD, MC. Analyzed the data: AD, MC, SD. Wrote the paper: AD, SD. All authors read and approved the final manuscript.”
“Background In the past, E. faecium was considered to be a harmless commensal of the mammalian GI tract and was used as a probiotic in fermented foods [1, 2]. In recent decades, E. faecium has been recognised as an opportunistic pathogen that causes diseases such as neonatal meningitis, urinary tract infections, bacteremia, bacterial endocarditis and diverticulitis [3–7]. Therefore, E. faecium can penetrate and survive in many environments in the human body, which could potentially lead to unpredictable consequences. Due to revolutionary advances in high-throughput DNA sequencing technologies [8] and computer-based genetic analyses, genome decoding and transcriptome sequencing (RNA-seq) [9, 10] analyses are rapid and available at low costs.